Sahajanand Medical IPO

Listed Mainboard
Min Investment
₹14,792
43 Shares
Min Investment
₹14,792 · 43 Shares
Price Band ₹327–344
Lot Size 43 shares
Issue Size ₹476 Cr
Listed At ₹371.15 +7.9%
Subscribed 14.2×
Listed On BSE & NSE

Sahajanand Medical IPO Listing Day Performance

Sahajanand Medical listed on BSE & NSE on 23 October 2026 at ₹371.15, a 7.89% premium over the issue price of ₹344. A retail investor allotted one lot of 43 shares gained ₹1,167 at the listing price.

Issue price
₹344
upper band
Listing price
₹371.15
pre-open auction
Listing gain
+7.89%
+₹27.15 per share
Profit per application
+₹1,167
43 shares

GMP vs actual listing

Last GMP before listing₹17 (+4.9%)
GMP-implied listing₹361
Actual listing₹371.15
Difference+₹10.15 (+2.8%)

Demand going into listing

Subscribed overall14.2×
QIB34.7×
NII14.64×
Retail3.03×
Listing price = opening price from the exchange's pre-open call auction on listing day. Watch live price

Market Sentiment

Grey Market Premium What is GMP?
+₹17
+4.9% ▲ ₹1 since last update
Est. listing ₹361
Upper price ₹344
GMP range ₹15 – ₹25
19 Oct · ₹24 23 Oct · ₹17
Updated 23 Oct, 12:05 am IST Unofficial grey-market data
GMP estimate ₹361
Actual listing ₹371.15
Listed above the GMP estimate by ₹10.15 (+2.8%)
Subscription Status
QIB
34.70x
NII
14.64x
bNII (>10L)
16.37x
sNII (2-10L)
11.19x
Retail
3.03x
Employee
0.37x
Total
14.20x
Updated: Oct 19, 2026 5:59 pm IST
Analysis Score 61 / 100
Data: 80%
GMP Score · 44% weight 40
Subscription Score · 38% weight 85
Financial Health · 19% weight 60
Weighted average of the parts above; updates as GMP and subscription change. not investment advice.

IPO Details

Price Band₹327–344 per equity share
Face Value₹1 Per Equity Share
Lot Size 43 shares (Min ₹14,792)
Total Issue Size ₹475.50 crore
Issue TypeBook build Issue
Lead Managers Motilal Oswal Investment Advisors Ltd. , Avendus Capital Pvt.Ltd.
Registrar MUFG Intime India Pvt. Ltd.
PromotersBhargav Dhirajlal Kotadia, Dhirajlal Vallabhbhai Kotadia, Priyanka Dhirajlal Cohen and Shree Hari Trust
Listing atBSE & NSE
BSE Code545001
NSE SymbolSMT
ISININE356Y01018
Listing Price₹371.15
Listing Gain+7.89%

Day-wise Subscription (times subscribed)

QIB
NII
Retail
Employee
Total
Each panel has its own scale.
Category Day 1 Day 2 Final
QIB 0.37x 1.12x 34.70x
NII 0.20x 0.51x 14.64x
bNII > ₹10L 0.13x 0.38x 16.37x
sNII 2-10L 0.36x 0.77x 11.19x
Retail 0.40x 0.83x 3.03x
Employee 0.08x 0.14x 0.37x
Total 0.34x 0.82x 14.20x

Market Lot Size

Category Lots Shares Amount (₹)
Retail Minimum 1 43 ₹14,792
Retail Maximum 13 559 ₹1,92,296
S-HNI Minimum 14 602 ₹2,07,088
S-HNI Maximum 67 2,881 ₹9,91,064
B-HNI Minimum 68 2,924 ₹10,05,856

IPO Reservation

QIB 27.8% NII 20.9% Retail 48.7% Employee & others 2.6%
Category Shares Offered Shares %
QIB27,14,42327.84%
NII (HNI)20,35,81820.88%
bNII > ₹10L13,57,21213.92%
sNII < ₹10L6,78,6066.96%
Retail47,50,24148.72%
Employee2,50,0002.56%
Total97,50,482

Financial Analysis

Financial Data

EPS (Pre)
₹6.67
ROCE
11.57%
RoNW
10.60%
EBITDA Margin
14.10%
NAV/Share
₹62.76
Revenue Growth
17.64%
Profit Margin
5.67%

Financial Performance

2026 vs 2025 Revenue +17.6% Profit (PAT) +174.7% Total Assets +16.6%
Metric 2024 2025 2026 June 2026
Revenue 908.59 1,035.96 1,218.73 354.33
Expense 875.50 980.12 1,138.43 330.05
Profit (PAT) 7.35 25.15 69.08 15.09
Total Assets 970.58 1,094.90 1,276.43 1,308.10
Values in Crores (₹)

Peer Comparison

Company EPS P/E RoNW % NAV Income
Sahajanand Medical This IPO 6.67 - 10.60 62.76 -
Poly Medicure Limited 31.79 51.40 10.37 306.40 1,875.26 Cr
Laxmi Dental Limited 5.27 36.35 11.91 44.27 277.86 Cr
Peer median P/E 43.9x across 2 listed peers

Strengths & Risks

Strengths
  • Heavily oversubscribed — 14.2x overall (final).
  • Strong institutional (QIB) demand — 34.7x.
  • Revenue grew 18% in the latest reported year.
Risks & Concerns

Our data checks haven't flagged a specific concern for Sahajanand Medical — but that isn't a clean bill of health. Read the risk-factors section of the RHP, which lists company-specific risks our data can't capture.

From this issue's live data. Not investment advice — read the RHP.

Sahajanand Medical IPO: Lead Manager & Registrar Track Record

Lead manager: Motilal Oswal Investment Advisors Ltd.

Apart from Sahajanand Medical, Motilal Oswal Investment Advisors Ltd. has managed 19 IPOs we track (19 Mainboard, 0 SME). Of the 19 that have listed, 16 opened at or above the issue price (84%), with an average listing-day move of +11.3% and a median of +6.7%. The average across all 114 Mainboard listings we track is +13.6%.

Best listing: CMR Green Technologies +43.4% · Weakest: Waterways Leisure Tourism −15.7%

Most recent listings managed by Motilal Oswal Investment Advisors Ltd.
IPOListedListing-day move
EAAA India Alternatives 02 Nov 2026 +0.6%
Fusion CX 22 Oct 2026 +5.5%
NSE 24 Sept 2026 +0.8%
Manipal Payment 17 Sept 2026 −2.1%
LCC Projects 17 Sept 2026 +31.4%

Lead manager: Avendus Capital Pvt.Ltd.

Apart from Sahajanand Medical, Avendus Capital Pvt.Ltd. has managed 6 IPOs we track (6 Mainboard, 0 SME). Of the 6 that have listed, 5 opened at or above the issue price (83%), with an average listing-day move of +2% and a median of +2.6%. The average across all 114 Mainboard listings we track is +13.6%.

Best listing: SEDEMAC Mechatronics +13.5% · Weakest: Amagi Media Labs −12.2%

Most recent listings managed by Avendus Capital Pvt.Ltd.
IPOListedListing-day move
Zetwerk 23 Oct 2026 +5.5%
NSE 24 Sept 2026 +0.8%
Symbiotec Pharmalab 01 Sept 2026 +0%
LEAP India 14 Aug 2026 +4.3%
SEDEMAC Mechatronics 11 Mar 2026 +13.5%

Lead manager: HSBC Securities & Capital Markets (India) Pvt.Ltd.

Apart from Sahajanand Medical, HSBC Securities & Capital Markets (India) Pvt.Ltd. has managed 7 IPOs we track (7 Mainboard, 0 SME). Of the 7 that have listed, 6 opened at or above the issue price (86%), with an average listing-day move of +6.7% and a median of +6.7%. The average across all 114 Mainboard listings we track is +13.6%.

Best listing: Jio Platforms +21.4% · Weakest: Clean Max Enviro −8.8%

Most recent listings managed by HSBC Securities & Capital Markets (India) Pvt.Ltd.
IPOListedListing-day move
Jio Platforms 28 Oct 2026 +21.4%
Zetwerk 23 Oct 2026 +5.5%
Juniper Green Energy 06 Aug 2026 +8.9%
Cube Highways Trust InvIT 31 Jul 2026 +2%
SBI Funds Management 21 Jul 2026 +6.7%

Lead manager: Nuvama Wealth Management Ltd.

Apart from Sahajanand Medical, Nuvama Wealth Management Ltd. has managed 12 IPOs we track (12 Mainboard, 0 SME). Of the 11 that have listed, 9 opened at or above the issue price (82%), with an average listing-day move of +4.4% and a median of +3.9%. The average across all 114 Mainboard listings we track is +13.6%.

Best listing: Augmont Enterprises +22% · Weakest: Powerica −7.3%

Most recent listings managed by Nuvama Wealth Management Ltd.
IPOListedListing-day move
SFC Environmental 03 Nov 2026 +7.6%
EAAA India Alternatives 02 Nov 2026 +0.6%
Paras Healthcare 28 Oct 2026 +3.9%
Fusion CX 22 Oct 2026 +5.5%
NSE 24 Sept 2026 +0.8%

Registrar: MUFG Intime India Pvt. Ltd.

MUFG Intime India Pvt. Ltd. is the registrar for 65 other IPOs we track (43 Mainboard, 22 SME). It finalises the basis of allotment, credits shares and processes refunds for Sahajanand Medical; 46 of the 62 it handled that have listed opened at or above the issue price.

How Sahajanand Medical compares with recent Mainboard IPOs

  • Subscribed 14.2x overall, against a median of 20.56x for the 111 Mainboard IPOs listed in the last 12 months — higher than 46% of them.
  • Listed at +7.9% on day one, against a median of +6.7% for 113 Mainboard listings in the last 12 months — better than 55% of them.

Listing-day move = exchange opening price vs issue price (band ceiling where the final price isn't recorded). Past listings don't predict this one.

Company Information

Sahajanand Medical at a glance

From the company's description: “Incorporated in 2001, Sahajanand Medical Technologies is a medical device firm that focuses on Class III and Class C/D devices, mainly working in the fields of vascular and structural heart intervention.”

Sahajanand Medical is raising ₹476 crore through an IPO on the BSE and NSE mainboard.

Revenue went from ₹909 crore in 2024 to ₹1,219 crore in 2026, up 34% over 2 years. Profit after tax went from ₹7.35 crore to ₹69.08 crore, a net margin of 5.7% in the latest year.

Written from the issue's offer-document figures shown on this page. Not investment advice.

Company Contact Information

Sahajanand Medical Technologies Ltd., Sahajanand Estate, Wakharia Wadi,, NR. Dabholi Char Rasta, Nani Ved, Ved Road, Surat, Gujarat, 395004

Resources & Documents

Sahajanand Medical IPO - Quick Take

Sahajanand Medical has set a price band of Rs 327–Rs 344 per share for an issue size of Rs 476 crore. The stock listed with a 7.89% gain versus its issue price on October 23, 2026.

The issue is promoted by Bhargav Dhirajlal Kotadia, Dhirajlal Vallabhbhai Kotadia, Priyanka Dhirajlal Cohen and Shree Hari Trust with Motilal Oswal Investment Advisors Ltd., Avendus Capital Pvt.Ltd., HSBC Securities & Capital Markets (India) Pvt.Ltd., Nuvama Wealth Management Ltd. acting as lead manager.

On fundamentals, the company is posting revenue growth of 17.6%, a profit margin of 5.7% in its most recent reported period. Listed peers in this segment include Poly Medicure Limited (P/E 51.40x) and Laxmi Dental Limited (P/E 36.35x) — useful reference points when evaluating the issue's pricing relative to where the broader sector is trading.

On our data-signal score, the combined signals for this issue currently read strong — the composite picture tilts positive, though not without some caveats. This is a summary of public data, not a recommendation to apply or skip. Past performance does not predict future returns — review the price chart and peer comparison below before trading.

Frequently Asked Questions

Sahajanand Medical listed at Rs 371.15 on 23 October 2026, against an issue price of Rs 344 — a 7.89% premium.

+7.89% at the listing price — Rs 27.15 per share, or Rs 1,167 on the minimum retail application of 43 shares.

The price band of Sahajanand Medical IPO is Rs 327 to Rs 344 per share. Face value is Rs 1 per share.

The total issue size of Sahajanand Medical IPO is Rs 476 crore.

The lot size of Sahajanand Medical IPO is 43 shares. The minimum application is 1 lot (43 shares), requiring an investment of Rs 14,792. Maximum retail application is 13 lots (559 shares, approx Rs 1,92,296).

Sahajanand Medical IPO opens for subscription on October 15, 2026 and closes on October 19, 2026.

The expected allotment date for Sahajanand Medical IPO is October 21, 2026. Refunds for unsuccessful applicants are expected on October 22, 2026. Shares are scheduled to be credited to demat accounts on October 22, 2026.

Sahajanand Medical IPO is scheduled to list on October 23, 2026 on both BSE and NSE. BSE script code: 545001, NSE symbol: SMT, ISIN: INE356Y01018.

The last GMP (Grey Market Premium) recorded for Sahajanand Medical IPO before listing was +Rs 17 (+4.9% over issue price). The shares actually listed at Rs 371.15 (+7.89% versus the issue price). GMP only estimates the listing price and stops mattering once the shares trade.

Sahajanand Medical IPO was subscribed 14.20 times overall by the close of bidding — retail at 3.03x, QIB at 34.70x, NII at 14.64x.

Based on the final retail subscription of 3.03x for Sahajanand Medical IPO, the estimated retail allotment probability is approximately 37.6%. This is a moderate probability of allotment.

The registrar for Sahajanand Medical IPO is MUFG Intime India Pvt. Ltd. After the allotment date, you can check your allotment status on the registrar's official website by entering your PAN, application number, or demat account details. Allotment status is also available on the BSE and NSE websites.

The book running lead manager(s) for Sahajanand Medical IPO are Motilal Oswal Investment Advisors Ltd., Avendus Capital Pvt.Ltd., HSBC Securities & Capital Markets (India) Pvt.Ltd., Nuvama Wealth Management Ltd.

The promoter(s) of Sahajanand Medical are Bhargav Dhirajlal Kotadia, Dhirajlal Vallabhbhai Kotadia, Priyanka Dhirajlal Cohen and Shree Hari Trust.

Sahajanand Medical IPO GMP — What It Means

Its last GMP before listing was 4.9%. Of the 40 Mainboard IPOs we have tracked with a final GMP under 10%, 27 listed above, 6 flat and 7 below the issue price; Sahajanand Medical listed 7.9% above its issue price.

See the full Sahajanand Medical GMP history and trend, or learn how grey market premium works and how reliable it is.

Related IPO

Same sector or same stage as Sahajanand Medical
Side by side: GMP, subscription, valuation, financials and listing performance.
0 Comments

No comments yet. Be the first to share your opinion!

GMPUpdate